Trial reportScientific reports2025
Effect of remineralization after in office followed by home treatment of white spot lesions in children randomized controlled trial.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06821724 (Comparative Study on the Effect of Different Remineralizing Agents Versus Fluoride Gel on White Spot Lesions After In-Office Followed by Home Treatment in Children), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparative Study on the Effect of Different Remineralizing Agents Versus Fluoride Gel on White Spot Lesions After In-Office Followed by Home Treatment in Children: A Randomized Controlled Clinical Study
Who cites it
3 citing papers in PubMed.
- Biomimetic Enamel Remineralization in Pediatric Dentistry: From Biological Principles to Clinical Evidence.Cureus · 2026Review
- Enamel Remineralizing Agents: State of the Art.Materials (Basel, Switzerland) · 2026Review
- Comparative effectiveness of remineralization agents on attachment-associated enamel demineralization in clear aligner patients: A 6-Month DIAGNOdent-Based controlled clinical trial.BMC oral health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To compare the effect of Nanohydroxy apatite (NHA), Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), CPP-ACP with fluoride (CPP-ACPF), versus fluoride gel on remineralization and color improvement of white spot lesions (WSLs) after clinical application followed by home treatment. Thirty-two children from 10 to 14 years with 100 teeth were participated in this study. Affected teeth were randomly allocated into five groups (n = 20); group I: NHA, group II: CPP-ACP, group III: CPP-ACP + F, group: IV: Fluoride gel and group V: no treatment. After application for five minutes, remineralization was assessed via diagnodent while Vita easy shade was used for color assessment before and after treatment. In- office procedures were repeated after one week and one month, while continuous home application was followed. Remineralization and color assessment were repeated at each interval. The remineralization ability and color change showed a significant difference between the examined groups at different intervals with p value < 0.001. Where group I had the significantly highest remineralization ability at different periods. While the color difference was significant in group III followed by group I after immediate application. However, at one-month group III had the most significant color change in all groups. NHA could be a potent remineralizing agent while improving the color of WSLs. CPP-ACP + F had a superior masking and sustainable effect of the WSLs. Combined in office followed by continuous home application of different remineralizing agents could mask the WSLs which satisfy the patients' needs.Trial registration: This study was initially registered on https://ClinicalTrials.gov on 12/02/2025 as first posted date, with ID: NCT06821724 - https://clinicaltrials.gov/study/NCT06821724 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.